germinal peptide
Peptideexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 20, 2018 (NCT03662971)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Thymosin beta-4Supplementation
TMSB4X supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03967548 | Phase 1 | Jun 20, 2019 | Capital Medical University, Lee's Pharmaceutical |
| NCT03662971 | Phase 1 | Sep 20, 2018 | Capital Medical University, Lee's Pharmaceutical |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Capital Medical University | Academic/Hospital | 2 | 0 | 1 | 2018 |
| Lee's Pharmaceutical | For profit | 2 | 2 | 1 | 2018 |
2 organizations
Page 1 / 1